Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sustained Release Oral Formulation for Treatment of Parkinson's Disease

NCT05471609 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT05471609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05471609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sustained Release Oral Formulation for Treatment of Parkinson's Disease
Lead sponsor
University of Minnesota
Phase
Phase 1
Overall status
Completed
Start date
June 12, 2025
Completion date
August 14, 2025
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers